TIDMPRX

RNS Number : 3333B

Proximagen Group PLC

16 April 2012

16 April 2012

Proximagen Group plc (the "Company")

Annual Report and Accounts

The Company confirms that further to sending the Annual Report and Accounts for the year ended 30 November 2011 to shareholders on 12 April 2012, an electronic copy of the Annual Report and Accounts is available in the Investor section of the Company's website at www.proximagen.com.

Enquiries

 
  Proximagen Group plc                 Tel: +44 (0)20 7400 7700 
   James Hunter, Finance Director 
 
   Singer Capital Markets (Nominated    Tel: +44 (0)20 3205 7500 
    Adviser) 
   Shaun Dobson/Claes Spang 
 
   M:Communications (Media enquiries)   Tel: +44 (0)20 7920 2330 
   Mary-Jane Elliott / Mary Clark       proximagen@mcomgroup.com 
    / Hollie Vile 
 
  About Proximagen 
  Proximagen Group plc (AIM:PRX) is a European biotechnology 
  company focused on the development and commercialisation 
  of novel therapeutics for diseases of the central nervous 
  system (CNS) and inflammation. 
 
  The Company is developing potential new best-in-class therapeutics 
  in its core disease areas including epilepsy, Parkinson's 
  disease, and Alzheimer's disease, as well as in other areas 
  such as inflammation, oncology and neuropathic pain. 
 
  Proximagen has a number of existing partnerships with pharmaceutical 
  companies including GlaxoSmithKline, Upsher-Smith and Lundbeck, 
  and is developing a broad pipeline of drug candidate programmes, 
  with four programmes in clinical development and more than 
  ten earlier stage assets being progressed. 
 
  Proximagen's strategy is to advance its pipeline with its 
  partners and to acquire innovative drug candidates that 
  complement its pipeline, with the objective of scaling 
  up its risk-mitigated operating model and generating sustainable 
  profits. 
 
  For more information, please visit www.proximagen.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSSFFFLDFESEIL

Proximagen Neuroscience (LSE:PRX)
Historical Stock Chart
From May 2024 to May 2024 Click Here for more Proximagen Neuroscience Charts.
Proximagen Neuroscience (LSE:PRX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Proximagen Neuroscience Charts.